Literature DB >> 21885342

Epigenetic mechanisms in systemic lupus erythematosus and other autoimmune diseases.

Christian M Hedrich1, George C Tsokos.   

Abstract

The pathogenic origin of autoimmune diseases can be traced to both genetic susceptibility and epigenetic modifications arising from exposure to the environment. Epigenetic modifications influence gene expression and alter cellular functions without modifying the genomic sequence. CpG-DNA methylation, histone tail modifications and microRNAs (miRNAs) are the main epigenetic mechanisms of gene regulation. Understanding the molecular mechanisms that are involved in the pathophysiology of autoimmune diseases is essential for the introduction of effective, target-directed and tolerated therapies. In this review, we summarize recent findings that signify the importance of epigenetic modifications in autoimmune disorders while focusing on systemic lupus erythematosus. We also discuss future directions in basic research, autoimmune diagnostics and applied therapy.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21885342      PMCID: PMC3225699          DOI: 10.1016/j.molmed.2011.07.005

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  99 in total

1.  The Microprocessor complex mediates the genesis of microRNAs.

Authors:  Richard I Gregory; Kai-Ping Yan; Govindasamy Amuthan; Thimmaiah Chendrimada; Behzad Doratotaj; Neil Cooch; Ramin Shiekhattar
Journal:  Nature       Date:  2004-11-07       Impact factor: 49.962

2.  Role of the CD6 glycoprotein in antigen-specific and autoreactive responses of cloned human T lymphocytes.

Authors:  N G Singer; B C Richardson; D Powers; F Hooper; F Lialios; J Endres; C M Bott; D A Fox
Journal:  Immunology       Date:  1996-08       Impact factor: 7.397

3.  Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis.

Authors:  Sandra Camelo; Antonio H Iglesias; Daehee Hwang; Brice Due; Hoon Ryu; Karen Smith; Steven G Gray; Jaime Imitola; German Duran; Basel Assaf; Brett Langley; Samia J Khoury; George Stephanopoulos; Umberto De Girolami; Rajiv R Ratan; Robert J Ferrante; Fernando Dangond
Journal:  J Neuroimmunol       Date:  2005-07       Impact factor: 3.478

4.  Rapid alteration of microRNA levels by histone deacetylase inhibition.

Authors:  Gary K Scott; Michael D Mattie; Crystal E Berger; Stephen C Benz; Christopher C Benz
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

5.  MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex.

Authors:  H H Ng; Y Zhang; B Hendrich; C A Johnson; B M Turner; H Erdjument-Bromage; P Tempst; D Reinberg; A Bird
Journal:  Nat Genet       Date:  1999-09       Impact factor: 38.330

6.  Processing of primary microRNAs by the Microprocessor complex.

Authors:  Ahmet M Denli; Bastiaan B J Tops; Ronald H A Plasterk; René F Ketting; Gregory J Hannon
Journal:  Nature       Date:  2004-11-07       Impact factor: 49.962

7.  Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs.

Authors:  Qianjin Lu; Ailing Wu; Bruce C Richardson
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

8.  Histone deacetylase inhibitor suppression of autoantibody-mediated arthritis in mice via regulation of p16INK4a and p21(WAF1/Cip1) expression.

Authors:  Keiichiro Nishida; Takamitsu Komiyama; Shin-Ichi Miyazawa; Zheng-Nan Shen; Takayuki Furumatsu; Hideyuki Doi; Aki Yoshida; Jiro Yamana; Masahiro Yamamura; Yoshihumi Ninomiya; Hajime Inoue; Hiroshi Asahara
Journal:  Arthritis Rheum       Date:  2004-10

9.  Genetic deficiency of C4, C2 or C1q and lupus syndromes. Association with anti-Ro (SS-A) antibodies.

Authors:  O Meyer; G Hauptmann; G Tappeiner; H D Ochs; F Mascart-Lemone
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

10.  Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus.

Authors:  M Herrmann; R E Voll; O M Zoller; M Hagenhofer; B B Ponner; J R Kalden
Journal:  Arthritis Rheum       Date:  1998-07
View more
  61 in total

1.  Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses.

Authors:  Clayton A White; Egest J Pone; Tonika Lam; Connie Tat; Ken L Hayama; Guideng Li; Hong Zan; Paolo Casali
Journal:  J Immunol       Date:  2014-11-12       Impact factor: 5.422

2.  Precision DNA demethylation ameliorates disease in lupus-prone mice.

Authors:  Hao Li; Maria G Tsokos; Sean Bickerton; Amir Sharabi; Yi Li; Vaishali R Moulton; Philip Kong; Tarek M Fahmy; George C Tsokos
Journal:  JCI Insight       Date:  2018-08-23

3.  Ethnic differences in DNA methyltransferases expression in patients with systemic lupus erythematosus.

Authors:  Kenneth L Wiley; Edward Treadwell; Kayihura Manigaba; Beverly Word; Beverly D Lyn-Cook
Journal:  J Clin Immunol       Date:  2012-10-09       Impact factor: 8.317

4.  cAMP-responsive element modulator α (CREMα) suppresses IL-17F protein expression in T lymphocytes from patients with systemic lupus erythematosus (SLE).

Authors:  Christian M Hedrich; Thomas Rauen; Katalin Kis-Toth; Vasileios C Kyttaris; George C Tsokos
Journal:  J Biol Chem       Date:  2011-12-19       Impact factor: 5.157

Review 5.  cAMP responsive element modulator: a critical regulator of cytokine production.

Authors:  Thomas Rauen; Christian M Hedrich; Klaus Tenbrock; George C Tsokos
Journal:  Trends Mol Med       Date:  2013-03-13       Impact factor: 11.951

6.  MBD-seq as a cost-effective approach for methylome-wide association studies: demonstration in 1500 case--control samples.

Authors:  Karolina A Aberg; Joseph L McClay; Srilaxmi Nerella; Lin Y Xie; Shaunna L Clark; Alexandra D Hudson; Jozsef Bukszár; Daniel Adkins; Christina M Hultman; Patrick F Sullivan; Patrik K E Magnusson; Edwin J C G van den Oord
Journal:  Epigenomics       Date:  2012-12       Impact factor: 4.778

7.  cAMP responsive element modulator (CREM) α mediates chromatin remodeling of CD8 during the generation of CD3+ CD4- CD8- T cells.

Authors:  Christian M Hedrich; José C Crispín; Thomas Rauen; Christina Ioannidis; Tomohiro Koga; Noe Rodriguez Rodriguez; Sokratis A Apostolidis; Vasileios C Kyttaris; George C Tsokos
Journal:  J Biol Chem       Date:  2013-12-02       Impact factor: 5.157

Review 8.  Small molecules in the treatment of systemic lupus erythematosus.

Authors:  Anastasia Markopoulou; Vasileios C Kyttaris
Journal:  Clin Immunol       Date:  2012-10-02       Impact factor: 3.969

Review 9.  Immunogenetics of systemic lupus erythematosus: A comprehensive review.

Authors:  Yogita Ghodke-Puranik; Timothy B Niewold
Journal:  J Autoimmun       Date:  2015-08-29       Impact factor: 7.094

10.  The catalytic subunit of protein phosphatase 2A (PP2Ac) promotes DNA hypomethylation by suppressing the phosphorylated mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) kinase (MEK)/phosphorylated ERK/DNMT1 protein pathway in T-cells from controls and systemic lupus erythematosus patients.

Authors:  Katsue Sunahori; Kamalpreet Nagpal; Christian M Hedrich; Masayuki Mizui; Lisa M Fitzgerald; George C Tsokos
Journal:  J Biol Chem       Date:  2013-06-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.